Accessibility: Skip TopNav
Amarna and NorthX signature
Henk Streefkerk (CEO Amarna Therapeutics) and Janet Hoogstraate (CEO NorthX Biologics) after finalizing the agreement
Format
JPEG
Quelle:
Amarna Therapeutics
Downloads
Originalgröße
Groß
Mittel
Klein